标题
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-13
DOI
10.1038/s41598-019-55641-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
- (2019) Suofu Ye et al. Scientific Reports
- Education and gastric cancer risk – An individual participant data meta‐analysis in the StoP project consortium
- (2019) Matteo Rota et al. INTERNATIONAL JOURNAL OF CANCER
- The role of thioredoxin system in cancer: strategy for cancer therapy
- (2019) Jin-Jing Jia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The thioredoxin system and cancer therapy: a review
- (2019) Fariba Mohammadi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality in China, 2014
- (2018) Wanqing Chen et al. Chinese Journal of Cancer Research
- Redox regulation of protein kinase C by selenometabolites and selenoprotein thioredoxin reductase limits cancer prevention by selenium
- (2018) Rayudu Gopalakrishna et al. FREE RADICAL BIOLOGY AND MEDICINE
- Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
- (2018) Junmin Zhang et al. MEDICINAL RESEARCH REVIEWS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario
- (2018) A. L. Mahar et al. Current Oncology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the Thioredoxin System for Cancer Therapy
- (2017) Junmin Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
- (2017) Gong Chen et al. Oncotarget
- Plasma thioredoxin reductase activity, a diagnostic biomarker, is up-regulated in resectable non-small cell lung cancers
- (2017) Ming Zhou et al. Translational Cancer Research
- The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma
- (2016) Maryam Sobhani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
- (2016) Yao Liang et al. Oncotarget
- Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress
- (2016) Chaoran Dong et al. Scientific Reports
- The thioredoxin system in breast cancer cell invasion and migration
- (2016) Maneet Bhatia et al. Redox Biology
- Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer
- (2015) Li-Kui Yin et al. Asian Pacific Journal of Cancer Prevention
- Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases
- (2015) Yang-Chun Zhou et al. Asian Pacific Journal of Cancer Prevention
- Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
- (2015) Chunyan Li et al. Oncotarget
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The thioredoxin antioxidant system
- (2013) Jun Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thioredoxin System in Cell Death Progression
- (2012) Jun Lu et al. ANTIOXIDANTS & REDOX SIGNALING
- Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis
- (2012) Bradley A. Carlson et al. CARCINOGENESIS
- The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
- (2011) Anna Maria Berghella et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systemic therapy for advanced gastric cancer: a clinical practice guideline
- (2011) M. MacKenzie et al. Current Oncology
- Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent
- (2011) Lihui Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
- (2010) Arne Holmgren et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
- (2009) Elias S.J. Arnér BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More